Gilbert & Cook »

Blueprint Medicines shares owned by Gilbert & Cook

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Gilbert & Cook from 13F filings

Historical chart of Gilbert & Cook investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Gilbert & Cook consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Gilbert & Cook

Quarter filed Position value Share count Share price at filing
2024-03-31 $467k 4.9k 94.86
2023-12-31 $447k 4.8k 92.24
2023-09-30 $224k 4.5k 50.22

More positions owned by Gilbert & Cook

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus Mid Cap Etf (IWR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus Top 200 Etf (IWL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ares Capital Corporation (ARCC)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Ishs 1-5yr Invs (IGSB)
United Parcel Service CL B (UPS)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)

View all positions for Gilbert & Cook

Top funds holding Blueprint Medicines

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Brown Advisory Holdings Incorporated
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Emerald Advisers
Point72 Asset Management
Bank of America Corporation

View all funds holding Blueprint Medicines